Clinical inertia in type 2 diabetes: A retrospective analysis of pharmacist-managed diabetes care vs. usual medical care

Pharmacy Practice

Volumn 11, Issue 4, 2013, Pages 203-210

  Yam, Felix K ^a   Adams, Aimee G ^b   Divine, Holly ^b   Steinke, Douglas ^c   Jones, Mikael D ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Delivery of health care; Diabetes mellitus; Efficiency; Pharmaceutical services; Type 2; United States

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; OUTCOME ASSESSMENT; PATIENT EDUCATION; PHARMACIST; PHYSICAL ACTIVITY; RETROSPECTIVE STUDY; SCREENING; SYSTOLIC BLOOD PRESSURE; TIME TO TREATMENT; TREATMENT OUTCOME;

EID: 84890898360     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552013000400005     Document Type: Article

References (18)

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.
2. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559. doi:10.1056/NEJMoa0802743
3. Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, Kaplan SH. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854-860. doi: 10.7326/0003-4819-151-12-200912150-00005
4. American Diabetes Association. Standards of Medical Care in Diabetes-2013. Diabetes Care. 2013;36(Suppl 1):S11-S66. doi: 10.2337/dc13-S011
5. Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13(Suppl 1):1-68.
6. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135(9):825-834.
7. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care. 2005;28(3):600-606.
8. Grant RW, Buse JB, Meigs JB; University HealthSystem Consortium (UHC) Diabetes Benchmarking Project Team. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28(2):337-442.
9. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173-184.
10. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (2003). 2003;43(2):149-159. doi: 10.1331/108658003321480696
11. Johnson CL, Nicholas A, Divine H, Perrier DG, Blumenschein K, Steinke DT. Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. J Am Pharm Assoc (2003). 2008;48(6):722-730. doi:10.1331/JAPhA.2008.07133
12. Divine H, Nicholas A, Johnson CL, Perrier DG, Steinke DT, Blumenschein K. PharmacistCARE: description of a pharmacist care service and lessons learned along the way. J Am Pharm Assoc (2003). 2008;48(6):793-802. doi:10.1331/JAPhA.2008.07132
13. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288(15):1909-1914.
14. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24(3):561-587.
15. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28(Suppl 1):S4-S36.
16. DeName B, Divine H, Nicholas A, Steinke DT, Johnson CL. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program. J Am Pharm Assoc (2003). 2008;48(6):731-736. doi: 10.1331/JAPhA.2008.07070
17. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
18. Zellmer WA, Cobaugh DJ, Chen D. Three signals from the Pharmacy Practice Model Summit. Am J Health Syst Pharm. 2011;68(12):1077. doi: 10.2146/ajhp110148